Skip to main content
News

MedImmune to Streamline Vaccine Operations in California

By July 23, 2012No Comments
Medimmune logo

Medimmune logo

MedImmune, the global biologics arm of AstraZeneca PLC, announced that it is restructuring its infectious disease and vaccines research, development and operations.  This will result in the closure of MedImmune’s Mountain View, CA and Santa Clara, CA sites, and consolidation of its infectious disease and vaccines research and development activities to other existing sites.  The changes are expected to be completed in 2014 to allow for a seamless transition of ongoing activities.

MedImmune’s Hayward, CA site will remain open with additional capabilities invested in the site.

{iframe}http://pressroom.medimmune.com/press-releases/2012/07/16/medimmune-to-streamline-vaccines-operations-in-california/{/iframe}

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.